Capital Fund Management S.A. Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $1.03 Million - $1.55 Million	-9,900 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$93.12 - $133.99 $921,888 - $1.33 Million	9,900 New	9,900 $1.08 Million
Q4 2018 Feb 13, 2019	SELL	$62.67 - $88.33 $1.4 Million - $1.98 Million	-22,400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $1.27 Million - $1.78 Million	14,500 Added 183.54%	22,400 $1.96 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $512,198 - $625,240	5,800 Added 276.19%	7,900 $778,000
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $3.12 Million - $4 Million	-26,900 Reduced 92.76%	2,100 $250,000
Q4 2017 Feb 09, 2018	BUY	$114.49 - $139.98 $3 Million - $3.67 Million	26,200 Added 935.71%	29,000 $3.68 Million
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $203,084 - $331,156	2,800	2,800 $329,000

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.